Skip to content

Brenntag SE Stock Faces Downgrade as Chemical Sector Struggles

A bleak outlook for Brenntag SE as analysts slash ratings. Can specialty chemicals save the struggling chemical distributor from further declines?

The image shows a screenshot of a computer screen with a stock market chart on it. The chart is...
The image shows a screenshot of a computer screen with a stock market chart on it. The chart is composed of various colors and text, providing a visual representation of the stock market.

Brenntag SE Stock Faces Downgrade as Chemical Sector Struggles

Brenntag SE, a global leader in chemical distribution, is facing renewed pressure after a recent downgrade by investment firm Jefferies. The company's shares have struggled to gain momentum, with analysts pointing to weak demand and rising costs as key challenges for the sector.

On March 13, 2026, Jefferies downgraded Brenntag SE to 'Underperform' and set a price target of €42—suggesting a potential 15% drop from current levels. The stock closed at €49.20 that day and has since remained stable, showing only a minor gain of 0.24% in recent trading on Xetra.

The downgrade follows broader concerns in the chemical distribution industry, where weak global demand—especially in automotive and construction—has weighed on performance. Brenntag's latest quarterly results highlighted persistent margin weakness, despite efforts to expand market share through acquisitions. While specialty chemicals may drive modest volume growth in 2026, organic growth has stayed flat. Other analysts have also turned cautious. Both Deutsche Bank and Warburg Research recently lowered their ratings for Brenntag SE to 'Hold'. The company's business model, which typically benefits from price fluctuations in chemicals, has not been enough to offset the current headwinds of rising input costs and sluggish demand.

Brenntag SE's shares continue to trade near €49.20, with little movement since the downgrade. The company's outlook remains tied to broader sector struggles, including weak demand in key industries and ongoing cost pressures. Analysts expect only gradual improvements, with specialty chemicals offering limited support for growth in the near term.

Read also:

Latest